Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Usage Information

Integrative 3D imaging and deep learning approach reveals cardiac fibroblast dynamics after myocardial infarction
Sheyla Barrado-Ballestero, María López-Moreno, Jorge Cobos-Figueroa, Max Hahn, Cristina Pogontke-Díaz, Tor Biering-Sørensen, Casper G. Salinas, Juan Antonio Guadix, José M. Perez-Pomares, Adrián Ruiz-Villalba, Urmas Roostalu
Sheyla Barrado-Ballestero, María López-Moreno, Jorge Cobos-Figueroa, Max Hahn, Cristina Pogontke-Díaz, Tor Biering-Sørensen, Casper G. Salinas, Juan Antonio Guadix, José M. Perez-Pomares, Adrián Ruiz-Villalba, Urmas Roostalu
View: Text | PDF
Resource and Technical Advance In-Press Preview Cardiology Cell biology

Integrative 3D imaging and deep learning approach reveals cardiac fibroblast dynamics after myocardial infarction

  • Text
  • PDF
Abstract

Cardiac fibroblasts (CFs) are key mediators of heart failure progression, driving fibrotic scar formation after myocardial infarction (MI). Conventional preclinical assessment of MI relies on two-dimensional histology, which cannot resolve the three-dimensional (3D) architecture of the injured heart. Understanding the molecular mechanisms of CF activation is critical for identifying new drug targets, yet spatial mapping of gene expression in intact hearts remains challenging. To address this, we developed a high-throughput imaging pipeline that combined single-cell–resolution gene expression profiling in cleared whole hearts with light-sheet fluorescence microscopy and an AI-driven analysis framework optimized for MI characterization. Using this approach, we mapped expression of periostin (Postn), collagen triple-helix repeat containing 1 (Cthrc1), and asporin (Aspn) — genes associated with CF activation. These markers were detected by day 3 post-infarction in the endocardium and border zone, preceding collagenous scar formation, then expanded across the infarcted myocardium before declining toward baseline during scar maturation. These findings revealed a spatially organized progression of fibrosis-associated gene expression that began in defined regions of the injured heart and subsequently extended throughout the infarcted myocardium. Whole-organ gene-expression imaging combined with deep-learning-based analysis enabled quantitative spatiotemporal mapping of molecular remodeling and provides a framework for investigating disease progression in intact organs.

Authors

Sheyla Barrado-Ballestero, María López-Moreno, Jorge Cobos-Figueroa, Max Hahn, Cristina Pogontke-Díaz, Tor Biering-Sørensen, Casper G. Salinas, Juan Antonio Guadix, José M. Perez-Pomares, Adrián Ruiz-Villalba, Urmas Roostalu

×

Usage data is cumulative from November 2026 through November 2026.

Usage JCI PMC
Totals 0 0
Total Views 0

Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.

Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.

Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts